Recombinant human serum albumin (OsrHSA) has emerged as a big innovation in the sphere of biopharmaceuticals, giving promising breakthroughs across a variety of health care and industrial apps. With its structural similarity to naturally derived human serum albumin, OsrHSA offers a safer, far more trustworthy option for therapeutic use, significant